High incidence of extended-spectrum β-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method

This publication has 10 references indexed in Scilit:

• Community Transmission of Extended-Spectrum ß-Lactamase
  Emerging Infectious Diseases, 2003
• Escherichia coli y Klebsiella pneumoniae productores de betalactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000)
  Enfermedades Infecciosas y Microbiología Clínica, 2003
• El significado clínico de las betalactamasas de espectro extendido
  Enfermedades Infecciosas y Microbiología Clínica, 2003
• Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by MultipleKlebsiella pneumoniaeClones in a Single Hospital (Madrid, 1989 to 2000)
  Antimicrobial Agents and Chemotherapy, 2002
• Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other Antimicrobial Drugs
  Antimicrobial Agents and Chemotherapy, 2002
• A 1998 Survey of Extended-Spectrum β-Lactamases in Enterobacteriaceae in France
  Antimicrobial Agents and Chemotherapy, 2000
• Outbreak of a Multiresistant Klebsiella pneumoniae Strain in an Intensive Care Unit: Antibiotic Use as Risk Factor for Colonization and Infection
  Clinical Infectious Diseases, 2000
• Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.
  Journal of Antimicrobial Chemotherapy, 1998
• Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases
  Antimicrobial Agents and Chemotherapy, 1998
• Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
  Infection, 1983